| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |